RetinalGenix Technologies Inc.
RTGN
$3.55
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 633.90K | 573.10K | 761.80K | 540.40K | 579.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 648.30K | 586.40K | 866.10K | 643.30K | 662.70K |
| Operating Income | -648.30K | -586.40K | -866.10K | -643.30K | -662.70K |
| Income Before Tax | -649.40K | -587.30K | -867.00K | -644.30K | -663.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -649.40K | -587.30K | -867.00K | -644.30K | -663.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -649.40K | -587.30K | -867.00K | -644.30K | -663.60K |
| EBIT | -648.30K | -586.40K | -866.10K | -643.30K | -662.70K |
| EBITDA | -648.30K | -586.30K | -866.00K | -643.30K | -662.60K |
| EPS Basic | -0.04 | -0.03 | -0.05 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.03 | -0.02 | -0.02 |
| EPS Diluted | -0.04 | -0.03 | -0.05 | -0.04 | -0.04 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.03 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 18.33M | 18.52M | 18.15M | 17.97M | 17.86M |
| Average Diluted Shares Outstanding | 18.33M | 18.52M | 18.15M | 17.97M | 17.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |